Tag:
BioXell
Latest Headlines
Latest Headlines
Italy's Cosmo to snap up BioXell in $41M deal
Faced with the fallout from a failed trial of its lead therapy, BioXell is following a familiar path taken by a lineup of European developers, agreeing to a buyout offer and joining forces with a
BioXell shares tank as lead drug fails mid-stage trial
Shares of Italy's BioXell SpA went into a dive this morning when the developer said that its experimental lead therapy for overactive bladder, Elocalcitol, failed a mid-stage trial. And the developer
